Biodistribution of anti-interleukin 2 receptor monoclonal antibodies correlates with their therapeutic efficacy following transplantation
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 123 (1) , 148-157
- https://doi.org/10.1016/0008-8749(89)90275-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- AGONISTIC AND ANTAGONISTIC INTERACTIONS OF ANTI-INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODIES IN RAT RECIPIENTS OF CARDIAC ALLOGRAFTSTransplantation, 1989
- Anti-interleukin 2 receptor monoclonal antibodies spare phenotypically distinct T suppressor cells in vivo and exert synergistic biological effects.The Journal of Experimental Medicine, 1988
- Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blastsMolecular Immunology, 1987
- The interleukin 2 receptor. Functional consequences of its bimolecular structure.The Journal of Experimental Medicine, 1987
- Interleukin 2 high-affinity receptor expression requires two distinct binding proteins.The Journal of Experimental Medicine, 1987
- Four epitopes on the rat 55-kDa subunit of the interleukin 2 receptor as defined by newly developed mouse anti-rat interleukin 2 receptor monoclonal antibodiesEuropean Journal of Immunology, 1987
- T suppressor lymphocytes reverse ongoing acute allograft rejectionHuman Immunology, 1985
- Expression of interleukin 2 receptors and binding of interleukin 2 by gamma interferon-induced human leukemic and normal monocytic cells.The Journal of Experimental Medicine, 1985
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- MIGRATION PATTERNS OF LYMPHOCYTES FROM RECIPIENTS OF ORGAN ALLOGRAFTS. I. THE UNMODIFIED HOSTTransplantation, 1981